I like TLX and it was my number 2 choice of all the listed biotechs when I did serious DD on them in mid 2019. I agree that it is not a CU6 verse TLX battle - TLX has the lead in clinical development and CU6 has the lead in efficacy.
Ann: Clarity strengthens Cu-64 network with new supply agreement, page-50
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.03 |
Change
-0.110(2.14%) |
Mkt cap ! $1.567B | |||
| Open | High | Low | Value | Volume |
| $5.10 | $5.11 | $4.94 | $5.510M | 1.099M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 35318 | $5.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.04 | 11673 | 1 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |